OncTimes Talk

Επεισόδια

• 
  The Future of Cancer Research: Clinical Trials, AI & Access to Care 05.10.2026 33λ

  In this episode of OncTimes Talk, Karen Knudsen, MBA, PhD, CEO of the Parker Institute for Cancer Immunotherapy, discusses barriers to clinical trial participation, the promise of AI in oncology, and the challenges facing cancer research funding. She explores why patient voices, equitable access, and a stronger translational research infrastructure are critical to the future of cancer care.
• 
  Targeting Tumor Acidity With Topical Bicarbonate Therapy 02.09.2026 18λ

  Dr. Shari Pilon-Thomas joins OncTimes Talk to discuss groundbreaking findings published in Frontiers in Immunology showing that topical bicarbonate treatment can counteract tumor acidosis and enhance anti-tumor immune responses. The conversation explores the science behind acidic tumor microenvironments, improved T-cell activity, and the clinical potential of this innovative immunotherapy approach.
• 
  Rethinking Breast Cancer Screening 12.08.2026 35λ

  In this episode of OncTimes Talk, Dr. Susan MacDonald interviews Dr. Barbara Levy about the evolution of breast cancer screening. Together, they discuss balancing early detection with overtesting, empowering patients to advocate for themselves, and designing healthcare systems that put people first.
• 
  Inside Lytix Biopharma's Breakthrough in Immunotherapy 18.05.2026 22λ

  In this episode, we explore how Lytix Biopharma is advancing a new kind of cancer treatment designed to both destroy tumors and train the immune system to fight back. Dr. Øystein Rekdal joins Dr. Susan McDonald to discuss the science behind LTX-315, a first-in-class oncolytic peptide, and its ability to trigger systemic immune responses even in heavily pretreated patients. From late-stage melanoma to earlier intervention strategies, this conversation highlights how reprogramming the tumor microenvironment could open new doors for patients and redefine the future of immunotherapy.
• 
  A Lap Around the Couch: Why Exercise Matters in Cancer Care 01.05.2026 34λ

  In this episode, Kathryn Schmitz, PhD, MPH, explains why movement should be treated like medicine for patients with cancer. In conversation with Susan MacDonald, MD, she breaks down the evidence, addresses common barriers, and offers practical guidance for both clinicians and patients. Resources mentioned in the podcast: Moving Through Cancer: An Exercise and Strength-Training Program for the Fight of Your Life movingthroughcancer.org 2Unstoppable
• 
  Understanding the Rise in Early-Onset Cancer 01.04.2026 34λ

  In this episode of Oncology Times, Dr. Susan MacDonald speaks with epidemiologist Dr. Mary Beth Terry about the alarming rise in early-onset cancers, particularly among women, and the role of environmental and lifestyle factors. They explore emerging evidence on alcohol use, plastics, vaping, and other exposures. Resources: Top 10 Tips for Healthier Home: General guidance on reducing exposures to hazardous chemicals in and round the home. Breast Cancer and the Environment: Simple steps for avoiding endocrine disrupting chemicals relevant to breast cancer. PFAS Exchange: An online resource center about PFAS contaminants in drinking water—helping communities understand their exposures and take action to protect their health. Includes medical guidance for healthcare providers. Detox Me mobile app (and more): Our free mobile app walks you through simple, research-based tips on how to limit your exposures to toxic chemicals where you live, work, and play. Includes top tips.
• 
  Championing Community Cancer Care 03.03.2026 27λ

  In this episode of OncTimes Talk, host Dr. McDonald speaks with Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance (COA) and a 23‑year breast cancer survivor. Rose shares her powerful personal cancer journey and how that experience ignited her lifelong commitment to patient advocacy. She discusses the essential role of community oncology practices, the challenges these centers face amid clinic closures and ongoing PBM interference, and why preserving local, accessible, innovative cancer care is critical for patients nationwide.
• 
  Radioactive Resilience: A Survivor's Mission to Cure Cancer 02.02.2026 19λ

  What happens when you survive a disaster that steals the lives of thousands of children?  For Dr. Yan Leyfman, surviving Chernobyl as a child wasn't just fate—it became the foundation of a lifelong mission to heal.  In this deeply personal conversation, Yan shares how tragedy shaped his calling in oncology, why empathy is the strongest medicine, and how innovation must not only save lives—but reach the patients who need it most. We explore the emotional weight of walking with patients through their darkest moments, the responsibility of a second chance at life, and a bold vision of equity that ensures hope isn't limited by geography or circumstance.  This episode is a testament to purpose, resilience, and the kind of medicine that doesn't just extend life—it honors it. 
• 
  Results from OncoExTra® Testing of 10K Tumor Samples Show the Next Generation of Sequencing 05.01.2026 12λ

  In this podcast episode, Dr. Christine Ibilibor meets with Dr. Jean-Paul De La O, a Senior Principal Medical Affairs Director at Exact Sciences, to talk about how comprehensive DNA and RNA sequencing of tumors has become easier, faster and more actionable for oncologists. The pair also discuss Exact Sciences' retrospective analysis of over 10,000 solid tumor samples profiled with the OncoExTra® test, and what the results revealed about biomarker testing.  
• 
  The Evolving Landscape of Bladder Cancer 02.01.2026 13λ

  In this episode of OncTimes Talk, we chat with Dr. Janet Kukreja about the evolving landscape of bladder cancer.
• 
  The Current State of Skin Cancer in the U.S. 01.12.2025 35λ

  In this episode of OncTimes Talk, Dr. Victor Czerkasij, DNP, DCNP, FNP-C, CWCP, MSN, MA discusses the current state of skin cancer in the U.S.
• 
  United Theranostics and the Future of Cancer Care 03.11.2025 1ώ 9λ

  In this episode of OncTimes Talk, we chat with Dr. Eliot Siegel, MD, FACR, FSIM, DABR; Dr. Michael Morris, MD, MS, DABR, DABNM, DCI; Dr. Babak Saboury, MD, MPH, DABR, DABNM; and Chief Medical Officer Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI from United Theranostics, a national leader in precision cancer care and radiopharmaceutical therapy. Together, these visionary physicians are advancing the frontiers of targeted cancer treatment, bringing innovative therapies and cutting-edge research to patients and communities across the country. We explore the evolution and future of radiopharmaceutical therapy, the challenges and opportunities in expanding access to advanced cancer care, and how United Theranostics is shaping the next generation of oncology practice.
• 
  Smashing Plates, Facing Fear: Heather Von St. James' Journey 01.10.2025 20λ

  At 36, Heather Von St. James was diagnosed with malignant pleural mesothelioma and given just 15 months to live. Nineteen years later, she's not only surviving, but she's also leading a movement. In this episode, Heather shares how she turned trauma into purpose, created a powerful annual ritual called "Lung Leavin' Day" and became a national voice for mesothelioma awareness. From motherhood to advocacy, Heather's voice is a reminder that even in the face of the unimaginable, purpose can take root.
• 
  Joey-Rose Jester on Life with Cholangiocarcinoma: A Conversation About Cancer, Work, and Everything in Between 01.09.2025 35λ

  In this episode of OncTimes Talk, we chat with Joey-Rose Jester, an exhibits manager and survivor of cholangiocarcinoma to explore the personal and professional sides of her cancer journey. From navigating a rare diagnosis to showing up at work during treatment, Joey-Rose shares honest reflections, unexpected lessons, and the moments that shaped her path.
• 
  From Ironman to Advocate: Tom Hulsey's Journey Through Prostate Cancer and Purpose 01.08.2025 26λ

  In this episode of OncTimes Talk, we chat with Tom Hulsey—athlete, author, and prostate cancer survivor—about the life-altering moment he received his diagnosis on his birthday, and how it set him on a path of resilience, advocacy, and renewed purpose. Tom opens up about the emotional toll of staying silent, the power of mindset in healing, and how facing both cancer and heart disease reshaped his outlook on life. He also shares insights from his work with medical research programs and offers powerful advice for men navigating their own health journeys. This is a conversation about vulnerability, strength, and the will to turn pain into purpose.
• 
  Accurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test 17.07.2025 19λ

  In this third episode of the OncoExTra® podcast series, host Ruchika Talwar, MD, talks with Christy Russell, MD, Vice President of Medical Affairs at Exact Sciences, about what oncologists can expect when they receive their OncoExTra comprehensive genomic profiling test results, and how they can utilize the report and tap into Exact Sciences' skilled support team to develop a plan of action for their patients.
• 
  Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield 01.07.2025 35λ

  In this episode of OncTimes Talk, we chat with Sami Mansfield, ACSM-CET, PN1, the founder of Cancer Wellness for Life, an organization dedicated to developing, implementing, and optimizing exercise oncology and lifestyle medicine programs and resources for hospitals, healthcare organizations, pharmaceutical companies, nonprofits, and individuals impacted by cancer. cancerwellnessforlife.com
• 
  Defying the Odds: Katie Colman's Journey from Diagnosis to Advocacy 02.06.2025 29λ

  In this episode of OncTimes Talk, we chat with Katie Colman. Diagnosed with an ultra-rare stage IV kidney cancer in 2020, her prognosis had a chance to significantly change after six months. Since then, Katie has since become an Author, founded a non-profit organization, and has become a podcast host—all with the goal of giving back to cancer research.   Katiekickscancer.com
• 
  Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing 28.05.2025 12λ

  In this podcast episode, host Ruchika Talwar, MD, is joined by Amin Mazloom, PhD, Senior Vice President of Bioinformatics, Biostatistics & Data Innovation, and Janine LoBello, DO, Senior Clinical Laboratory Medical Director at Exact Sciences to discuss patient-matched tumor-normal (PMTN) sequencing and why it matters for oncologists. Drs. Mazloom and LoBello discuss PMTN sequencing as a gold standard method for calculating tumor mutational burden and personalized therapy selection and share their thoughts on the future of cancer testing.
• 
  Patient-Matched Tumor-Normal Sequencing: What It Is and Why It Matters 28.05.2025 12λ

  In this podcast episode, host Ruchika Talwar, MD, is joined by Amin Mazloom, PhD, Senior Vice President of Bioinformatics, Biostatistics & Data Innovation, and Janine LoBello, DO, Senior Clinical Laboratory Medical Director at Exact Sciences to discuss patient-matched tumor-normal (PMTN) sequencing and why it matters for oncologists. Drs. Mazloom and LoBello discuss PMTN sequencing as a gold standard method for calculating tumor mutational burden and personalized therapy selection and share their thoughts on the future of cancer testing.